Lumos Diagnostics Holdings Limited (LDX.AX) Deep Dive Video
Summary
Lumos is a high-risk but potentially asymmetric medtech scale-up, with FDA-cleared, CLIA-waived FebriDx transforming a niche diagnostics developer into a U.S. outpatient commercialization story.